Sei Investments CO Bridge Bio Pharma, Inc. Transaction History

Sei Investments CO

$69 Billion
Q2 2024

A detailed history of Sei Investments CO transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Sei Investments CO holds 23,667 shares of BBIO stock, worth $590,254. This represents 0.0% of its overall portfolio holdings.

Number of Shares

23,667

Previous 49,778 52.45%

Holding current value

$590,254

Previous $1.54 Million 61.08%

% of portfolio

0.0%

Previous 0.0%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$23.0 - $31.04 $600,553 - $810,485	-26,111 Reduced 52.45%	23,667 $599,000
Q1 2024 May 07, 2024	SELL	$27.35 - $40.45 $171,758 - $254,026	-6,280 Reduced 11.2%	49,778 $1.54 Million
Q4 2023 Feb 14, 2024	BUY	$24.02 - $43.89 $466,108 - $851,685	19,405 Added 52.94%	56,058 $2.26 Million
Q3 2023 Nov 14, 2023	SELL	$16.89 - $35.01 $111,862 - $231,871	-6,623 Reduced 15.3%	36,653 $966,000
Q2 2023 Aug 11, 2023	SELL	$13.29 - $18.01 $95,222 - $129,041	-7,165 Reduced 14.2%	43,276 $744,000
Q1 2023 May 12, 2023	BUY	$7.17 - $18.55 $361,661 - $935,680	50,441 New	50,441 $836,000
Q3 2021 Nov 12, 2021	SELL	$46.87 - $64.24 $2.75 Million - $3.77 Million	-58,707 Closed	0 $0
Q2 2021 Aug 06, 2021	SELL	$46.47 - $63.93 $178,909 - $246,130	-3,850 Reduced 6.15%	58,707 $3.58 Million
Q1 2021 May 12, 2021	BUY	$55.47 - $72.35 $1.99 Million - $2.59 Million	35,791 Added 133.72%	62,557 $3.85 Million
Q4 2020 Feb 08, 2021	BUY	$38.38 - $71.11 $1.03 Million - $1.9 Million	26,766 New	26,766 $1.9 Million

Others Institutions Holding BBIO

# of Institutions

292

Shares Held

175M

Call Options Held

8.66M

Put Options Held

2.76M

View Full List

About BridgeBio Pharma, Inc.

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $3.7B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

More about BBIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sei Investments CO, based on Form 13F filings with the SEC.

News

Stay updated on Sei Investments CO with notifications on news.

Account

Sei Investments CO Bridge Bio Pharma, Inc. Transaction History